Get insight into trends in market performance
Pinpoint growth sectors and identify factors driving change
Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception;
Table of contents
OTC HEALTHCARE - SAUDI ARABIA : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 5 OTC Healthcare Switches
Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
OTC HEALTHCARE - SAUDI ARABIA : LOCAL COMPANY PROFILES
GLAXO SAUDI ARABIA LTD - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Glaxo Saudi Arabia Ltd/GlaxoSmithKline:
PRODUCTION CAPACITY
JULPHAR GULF PHARMACEUTICALS - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Julphar: Operational Indicators 2004
PRODUCTION CAPACITY
SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CO (SPIMACO) - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - SPIMACO: Operational Indicators 2004
PRODUCTION CAPACITY
TABUK PHARMACEUTICAL MANUFACTURING CO - OTC HEALTHCARE - SAUDI ARABIA
COMPANY BACKGROUND
RECENT NEWS
Summary 4 Summary - Tabuk Pharmaceutical Manufacturing Co: Operational Indicators 2004
PRODUCTION CAPACITY
ANALGESICS - SAUDI ARABIA : SECTOR BRIEFING
SECTOR PERFORMANCE
2005 headlines
Price increases, better distribution and advertising boost sales at healthier rate in 2005
GlaxoSmithKline’
SPIMACO second with good gains achieved in 2005 from Fevadol and Sapofen
Strong presence for foreign multinationals:
Adult analgesics
Child-specific analgesics
Topical analgesics
Forecast performance:
Table 12 Sales of Analgesics by Subsector: Value 2000-2005
Table 13 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 14 Analgesics Company Shares by Retail Value 2001-2005
Table 15 Analgesics Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Analgesics: New Product Launches 2004-2005
Table 16 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Table 18 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES - SAUDI ARABIA : SECTOR BRIEFING
SECTOR PERFORMANCE
2005 headlines
Value sales peaked in 2005 due to price increases, switching and new product launches
Switching, high incidence of allergy and high unit prices boost sales of systemic antihistamines/
Pharyngeal preparations retains its position as the most dynamic subsector in 2005
New innovations continued to stimulate sales of combination products in 2005
Medicated confectionery boosted by mainstream products with sales up steadily in 2005
SPIMACO confirms its leading position and gains share in 2005
Novartis benefits from withdrawals and gains share with Otrivin, Otrinol and Orofar
Strong presence for multinationals
Forecast performance:
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 6 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
For more information, Please visit :
http://www.bharatbook.com/
